Department of Laboratory Medicine, Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Department of infectious disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Scand J Gastroenterol. 2022 Dec;57(12):1486-1493. doi: 10.1080/00365521.2022.2098051. Epub 2022 Jul 14.
Whether hemostatic status was correlated with the diverse types of acute kidney injury in cirrhotic patients is unclear. The present study aimed to investigate the relationship between hemostatic markers and the diverse types of acute kidney injury (AKI) in liver cirrhosis.
Cirrhotic patients with consecutive treatment at the First Affiliated Hospital of Medicine School, Zhejiang University, were pooled in a cohort. Their demographic and clinical data, biochemistry parameters and hemostatic markers were assessed to identify risk factors for the development and prognosis of AKI.
A total of 773 cirrhotic patients were included in this cohort. Patients with hepatorenal syndrome (HRS) had significantly higher D-Dimer than those with the other types of AKI. In univariate COX regression, APTT, TT, INR, D-Dimer and Fib were correlated with the development of AKI, HRS and acute tubular necrosis (ATN), however, only D-Dimer remained independently associated with the development of AKI and HRS in multivariate COX regression. The area under the ROC curve of D-Dimer was 0.755 (95%CI, 0.718-0.793) in predicting the development of AKI, 0.879 (95%CI, 0.791-0.967) in predicting the development of HRS, respectively. D-Dimer was used for diagnosis of HRS with a sensitivity of 87.3% and specificity of 72.9% at the cutoff of 3.7 (mg/L FEU). Survival rates differed significantly between groups by D-Dimer level.
Hemostatic markers were significantly associated with the diverse types of AKI. D-Dimer was an independent risk factor for HRS and correlated with a poor outcome in cirrhotic patients.
肝硬变患者止血状态与各种类型急性肾损伤之间的关系尚不清楚。本研究旨在探讨止血标志物与肝硬变患者各种类型急性肾损伤(AKI)之间的关系。
收集浙江大学医学院附属第一医院连续治疗的肝硬变患者队列。评估其人口统计学和临床数据、生化参数和止血标志物,以确定 AKI 发展和预后的危险因素。
该队列共纳入 773 例肝硬变患者。肝肾综合征(HRS)患者的 D-二聚体明显高于其他类型 AKI 患者。单因素 COX 回归分析显示,APTT、TT、INR、D-二聚体和 Fib 与 AKI、HRS 和急性肾小管坏死(ATN)的发生相关,但多因素 COX 回归分析显示,只有 D-二聚体与 AKI 和 HRS 的发生独立相关。D-二聚体预测 AKI 发生的 ROC 曲线下面积为 0.755(95%CI,0.718-0.793),预测 HRS 发生的 ROC 曲线下面积为 0.879(95%CI,0.791-0.967)。D-二聚体用于诊断 HRS 的截断值为 3.7(mg/L FEU)时,其敏感性为 87.3%,特异性为 72.9%。不同 D-二聚体水平组的生存率差异有统计学意义。
止血标志物与各种类型 AKI 显著相关。D-二聚体是 HRS 的独立危险因素,与肝硬变患者不良预后相关。